KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 147 filers reported holding KARUNA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $101,009,735 | +63.6% | 319,136 | -12.6% | 0.02% | +41.2% |
| Q3 2023 | $61,740,509 | -28.0% | 365,134 | -7.7% | 0.02% | -22.7% |
| Q2 2023 | $85,776,535 | +41.8% | 395,557 | +18.8% | 0.02% | +29.4% |
| Q1 2023 | $60,477,947 | +1.4% | 332,955 | +9.7% | 0.02% | 0.0% |
| Q4 2022 | $59,637,949 | -13.6% | 303,501 | -1.1% | 0.02% | -22.7% |
| Q3 2022 | $69,029,000 | +4083.6% | 306,895 | +2253.3% | 0.02% | – |
| Q2 2022 | $1,650,000 | +7.0% | 13,041 | +7.2% | 0.00% | – |
| Q1 2022 | $1,542,000 | +0.6% | 12,163 | +4.0% | 0.00% | – |
| Q4 2021 | $1,533,000 | -0.5% | 11,696 | -7.1% | 0.00% | – |
| Q3 2021 | $1,540,000 | +22.9% | 12,585 | +14.5% | 0.00% | – |
| Q2 2021 | $1,253,000 | +73.3% | 10,990 | +82.8% | 0.00% | – |
| Q1 2021 | $723,000 | +120.4% | 6,012 | +86.0% | 0.00% | – |
| Q4 2020 | $328,000 | -97.4% | 3,232 | -97.1% | 0.00% | -100.0% |
| Q2 2020 | $12,413,000 | – | 111,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
| PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
| Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
| ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
| Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
| Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
| Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
| EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
| EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
| MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |